Evidence map›Paper›PMID 39886964›Full record

ArticleOncology reports2025

[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling.

Yan-Hong Liu, Man Zhu, Pan-Pan Lei, Xiao-Yan Pan, Wei-Na Ma

Abstract readPublished Erratum
In one paragraph

Article in Oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Yan-Hong LiuSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Man ZhuSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Pan-Pan LeiSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Xiao-Yan PanSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Wei-Na MaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subsequently to the publication of the above article, and a Corrigendum that has already been published with the intention of showing a corrected version of Fig. 2A (DOI: 10.3892/or.2023.8518; published online on March 3, 2023), the authors have subsequently realized that other errors were featured in certain of the published figures. First, the authors realized that Fig. 3 on p. 5 was incorrectly assembled: specifically, the flow cytometric data included in Figs. 3A and 3B were inadvertently assembled incorrectly. Additionally, the authors note that the control GAPDH data were duplicated in Figs. 5A and 5B, 6A and 6B, and 7A and 7B on p. 7 and 8. These errors occurred on account of the fact that the authors chose to use the same GAPDH bands for quantitative analysis, which they subsequently realize was not an appropriate course of action; the original GAPDH bands pertaining to the correct experiments are now included in each of these figures. The revised versions of Figs. 3, 5, 6 and 7 are shown on the next two pages. Note that the revisions made to Figs. 3, 5, 6 and 7 in this paper do not have a major impact on the reported results, and neither do they affect the overall conclusions reported in the study. All the authors agree to the publication of this corrigendum. The authors are grateful to the Editor of

Indexed as

BCR‑ABLcell apoptosiscell cyclechronic myeloid leukemiaND‑09

Identifiers

PMID39886964
PMCPMC11795229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.